v3.26.3
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 71,826 $ 59,313 $ 217,333 $ 185,089
General and administrative 18,726 15,438 53,950 70,688
Total operating expenses 90,552 74,751 271,283 255,777
Loss from operations (90,552) (74,751) (271,283) (255,777)
Interest income (expense), net 4,486 3,613 13,903 11,207
Other income (expense), net (46) (1) (99) (23)
Net loss and comprehensive loss (86,112) (71,139) (257,479) (244,593)
Impact of preferred stock extinguishments and modifications       (9,396)
Net loss attributable to common stockholders $ (86,112) $ (71,139) $ (257,479) $ (253,989)
Net loss per share attributable to common stockholders, basic $ (1.59) $ (24.24) $ (5.43) $ (89.06)
Net loss per share attributable to common stockholders, diluted $ (1.59) $ (24.24) $ (5.43) $ (89.06)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Basic 54,168,268 2,934,921 47,412,330 2,851,910
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, Diluted 54,168,268 2,934,921 47,412,330 2,851,910